This collection compiles research and implementation materials from the Improving Addiction Care Team (IMPACT) program from Oregon Health & Science University (OHSU). IMPACT is an interprofessional, hospital-based addictions team that provides addiction medicine consults to patients being treated at OHSU who have a substance use disorder (SUD).
The Improving Addiction Care Team, or IMPACT, is an interprofessional hospital-based addictions team that meets people with substance use disorder (SUD) during the reachable moment of hospitalization at Oregon Health & Science University.
This resource captures Oregon Health & Science University’s practice recommendations for the management of pain in patients on buprenorphine undergoing surgery and pregnant women during labor, delivery, and the post-partum period.
A brief overview of Aware Recovery Care (ARC) substance use disorder (SUD) treatment model that provides in-home treatment from a multidisciplinary team of professionals. Operational in Connecticut and New Hampshire, the ARC model provides individualized, flexible services that address common barriers to accessing treatment such as difficulties with scheduling, or transportation, and provides SUD treatment in the person’s home environment where they will maintain their recovery. A study found that patients in ARC treatment models had recovery rates six times higher than the national average. Part of the Addiction Policy Forum’s Spotlight series which highlights innovative programs to address the opioid crisis.
This 1 page briefing paper summarizes the findings from a study of participants in In the Rooms, an online social network site for the recovery community. The study showed that recovery-specific social network sites show promise as part of the modern recovery community. More research into whether these sites help
The Covid-19 resources page of the Foundation for Opioid Response Efforts includes recordings of webinars created on Covid-19 topics and recent news.
This website is the Covid-19 public emergency response page of the California Bridge Project. The page includes guidance on keeping patients and providers safe, using telehealth to deliver treatment,
This Covid-19 information page of the American Society for Addiction Medicine (ASAM) provides information for clinicians who provide substance use disorder treatment.
This link is the home to the Covid-19 response website of the Substance Abuse and Mental Health Services Administration.
This 2018 guidance on telemedicine to prescribe buprenorphine was recently promoted by the Substance Abuse and Mental Health Services Administration (SAMHSA) as part of its Covid-19 public health emergency response. The guidance explains how telemedicine can be a solution to the lack of providers with a Drug Enforcement Administration waiver to prescribe buprenorphine. Part of a series of guidance letters issued by SAMSHA in March, 2020. Funding Source: U.S. Department of Health and Human Services